Keywords: واکسن مالاریا; Malaria vaccine; Infants; Acceptability; Mapping; Togo;
مقالات ISI واکسن مالاریا (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: واکسن مالاریا; Malaria vaccine; Targeted liposomes; Antigen delivery system; Protective immune response; Antigen presenting cells;
Keywords: واکسن مالاریا; Multimodal; Mixed-mode; QbD; DoE; Optimization strategy; Malaria vaccine
Keywords: واکسن مالاریا; CDP; clinical development plan; CHMI; controlled human malaria infection; CRT; cluster-randomized trial; DFA; direct feeding assay; DMFA; direct membrane feeding assay; malERA; Malaria Eradication Research Agenda; MALVAC; malaria vaccine advisory committe
Accelerated and long term stability study of Pfs25-EPA conjugates adjuvanted with Alhydrogel®
Keywords: واکسن مالاریا; EPA; ExoProtein A; Malaria; Malaria vaccine; Pfs25; Pfs25-EPA conjugate; Transmission blocking vaccine;
Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa
Keywords: واکسن مالاریا; RTS,S; Malaria vaccine; Cost-effectiveness; Modelling and simulation;
Comparative functional potency of DNA vaccines encoding Plasmodium falciparum transmission blocking target antigens Pfs48/45 and Pfs25 administered alone or in combination by in vivo electroporation in rhesus macaques
Keywords: واکسن مالاریا; Malaria vaccine; Transmission; DNA vaccine; Combination vaccine; Target antigen; Mosquitoes;
A potent malaria vaccine based on adenovirus with dual modifications at Hexon and pVII
Keywords: واکسن مالاریا; Ad; adenovirus; rAd; recombinant adenovirus; Ad5; adenovirus serotype 5; CSP; circumsporozoite protein; HVR; hyper-variable region; PfCSP; Plasmodium falciparum CSP; pVII; adenovirus core protein VII; v.p; virus particle; Adenovirus; Malaria vaccine; Caps
The s48/45 six-cysteine proteins: mediators of interaction throughout the Plasmodium life cycle
Keywords: واکسن مالاریا; Malaria; Plasmodium; s48/45; 6-cys proteins; Adhesion proteins; Host-pathogen interactions; Malaria vaccine;
Immunogenicity and protection from malaria infection in BK-SE36 vaccinated volunteers in Uganda is not influenced by HLA-DRB1 alleles
Keywords: واکسن مالاریا; HLA-DRB1; Malaria vaccine; BK-SE36; Clinical malaria; Immune tolerance;
Immunogenicity and immunizing protection effect of GAMA gene DNA vaccine on Plasmodium berghei
Keywords: واکسن مالاریا; Malaria vaccine; DNA vaccine; Multi-stage vaccine; GAMA; Plasmodium berghei
Decrease in circulating CD25hiFoxp3+ regulatory T cells following vaccination with the candidate malaria vaccine RTS,S
Keywords: واکسن مالاریا; Malaria vaccine; RTS,S; Heterologous prime-boost; Plasmodium falciparum; Circumsporozoite protein; Regulatory T cell;
Co-administration of α-GalCer analog and TLR4 agonist induces robust CD8+ T-cell responses to PyCS protein and WT-1 antigen and activates memory-like effector NKT cells
Keywords: واکسن مالاریا; Adjuvant; Glycolipid; NKT cells; CD1d; TLR4; Malaria vaccine; Cancer vaccine; WT-1; Circumsporozoite protein; Memory-like effector NKT cells;
Immunogenicity of a plasmid DNA vaccine encoding 42Â kDa fragment of Plasmodium vivax merozoite surface protein-1
Keywords: واکسن مالاریا; DNA vaccine; Malaria vaccine; Erythrocytic stage; P. vivax; PvMSP-142;
Sequence polymorphisms of Plasmodium vivax tryptophan and alanine rich antigen (PvTARAg55)
Keywords: واکسن مالاریا; Plasmodium vivax; PvTARAg55; Polymorphism; Malaria vaccine; Korea;
Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines
Keywords: واکسن مالاریا; Malaria vaccine; Plasmodium falciparum; Sporozoite; PfSPZ Vaccine; PfSPZ-CVac; PfSPZ Challenge;
Immune protection-inducing protein structures (IMPIPS) against malaria: the weapons needed for beating Odysseus
Keywords: واکسن مالاریا; IMPIPS; Malaria vaccine; Synthetic peptides; Modified peptides;
NIAID meeting report: Improving malaria vaccine strategies through the application of immunological principles
Keywords: واکسن مالاریا; Malaria vaccine; Adaptive immunity; Innate immunity; Conference report;
Sequential Phase 1 and Phase 2 randomized, controlled trials of the safety, immunogenicity and efficacy of combined pre-erythrocytic vaccine antigens RTS,S and TRAP formulated with AS02 Adjuvant System in healthy, malaria naïve adults
Keywords: واکسن مالاریا; TRAP; RTS,S; AS02; Immune interference; Malaria vaccine; Challenge;
Cloning, overexpression and characterization of soluble 42 kDa fragment of merozoite surface protein-1 of Plasmodium vivax
Keywords: واکسن مالاریا; Malaria; Malaria vaccine; Merozoite surface protein-1; Plasmodium vivax
Approaching the community about screening children for a multicentre malaria vaccine trial
Keywords: واکسن مالاریا; Community sensitisation; Malaria vaccine; Clinical trials; Informed consent
Naturally acquired antibodies to Plasmodium vivax blood-stage vaccine candidates (PvMSP-119 and PvMSP-3α359â798) and their relationship with hematological features in malaria patients from the Brazilian Amazon
Keywords: واکسن مالاریا; Plasmodium vivax; Merozoite antigens; Malaria vaccine; Antibodies;
The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development
Keywords: واکسن مالاریا; Malaria vaccine; Sporozoite vaccine; Plasmodium yoelii; Plasmodium vinckei; Pre-erythrocytic stage; Blood stage
A polyvalent hybrid protein elicits antibodies against the diverse allelic types of block 2 in Plasmodium falciparum merozoite surface protein 1
Keywords: واکسن مالاریا; Antigenic polymorphism; Plasmodium falciparum; Malaria vaccine; Merozoite;
Adenovirus particles that display the Plasmodium falciparum circumsporozoite protein NANP repeat induce sporozoite-neutralizing antibodies in mice
Keywords: واکسن مالاریا; Malaria vaccine; Recombinant adenovirus; Capsid display; Immunogenicity;
Identification of non-CSP antigens bearing CD8 epitopes in mice immunized with irradiated sporozoites
Keywords: واکسن مالاریا; Plasmodium; Malaria vaccine; Circumsporozoite protein (CSP); Non-CSP antigens;
Induction of humoral immune response against PfMSP-119 and PvMSP-119 using gold nanoparticles along with alum
Keywords: واکسن مالاریا; Malaria vaccine; PfMSP119; Gold nanoparticles based delivery
Blood stage merozoite surface protein conjugated to nanoparticles induce potent parasite inhibitory antibodies
Keywords: واکسن مالاریا; Adjuvant; Malaria vaccine; Nanoparticles; Dendritic cells; Inhibitory antibodies
Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambaréné, Gabon
Keywords: واکسن مالاریا; Malaria vaccine; Phase I clinical trial; Malaria immunity
Stability and potency of the Plasmodium falciparum MSP1-19/AMA-1(III) chimeric vaccine candidate with Montanide ISA720 adjuvant
Keywords: واکسن مالاریا; Malaria vaccine; Potency assay; PfCP-2.9 antigen; Montanide ISA720;
3D structure determination of STARP peptides implicated in P. falciparum invasion of hepatic cells
Keywords: واکسن مالاریا; Structure; 1H NMR; Malaria vaccine; Sporozoite;
MALVAC 2009: Progress and Challenges in Development of Whole Organism Malaria Vaccines for Endemic Countries, 3–4 June 2009, Dakar, Senegal
Keywords: واکسن مالاریا; Malaria vaccine; P. falciparum; Clinical trial; Conference report
Randomized double-blind controlled Phase I/IIa trial to assess the efficacy of malaria vaccine PfCS102 to protect against challenge with P. falciparum
Keywords: واکسن مالاریا; Phase IIa; Malaria vaccine; Sporozoite; Plasmodium falciparum;
Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates
Keywords: واکسن مالاریا; Simian adenovirus; MVA; Malaria vaccine; Macaque;
Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-γ/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection
Keywords: واکسن مالاریا; Malaria vaccine; Plasmodium falciparum; Liver Stage Antigen
Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan Children, in the context of vaccine vector efficacy
Keywords: واکسن مالاریا; Simian adenoviral vector; Malaria vaccine; Vector neutralizing antibodies
MALVAC 2008: Measures of efficacy of malaria vaccines in phase 2b and phase 3 trials—Scientific, regulatory and public health perspectives
Keywords: واکسن مالاریا; Malaria vaccine; Clinical trial; Efficacy
Development of the RTS,S/AS malaria candidate vaccine
Keywords: واکسن مالاریا; Malaria vaccine; RTS,S/AS; Development
Genetic diversity of transmission blocking vaccine candidate (Pvs25 and Pvs28) antigen in Plasmodium vivax clinical isolates from Iran
Keywords: واکسن مالاریا; Plasmodium vivax; Ookinete surface protein 25 (Pvs25); Pvs28; Genetic diversity; Malaria vaccine
Report of a Consultation on the Optimization of Clinical Challenge Trials for Evaluation of Candidate Blood Stage Malaria Vaccines, 18–19 March 2009, Bethesda, MD, USA
Keywords: واکسن مالاریا; Malaria vaccine; Clinical trial; P. falciparum; P. vivax
Genetic diversity in the C-terminal 42 kDa region of merozoite surface protein-1 of Plasmodium vivax (PvMSP-142) among Indian isolates
Keywords: واکسن مالاریا; Plasmodium vivax; Merozoite surface protein; Genetic diversity; Malaria vaccine; Natural selection
Preclinical assessment of the receptor-binding domain of Plasmodium vivax Duffy-binding protein as a vaccine candidate in rhesus macaques
Keywords: واکسن مالاریا; Malaria vaccine; Duffy-binding protein; Plasmodium vivax; Adjuvant formulation;
Development of pilot scale production process and characterization of a recombinant multiepitope malarial vaccine candidate FALVAC-1A expressed in Escherichia coli
Keywords: واکسن مالاریا; Plasmodium falciparum; Malaria vaccine; Bioprocess; Escherichia coli
Production, quality control, stability and pharmacotoxicity of cGMP-produced Plasmodium falciparum AMA1 FVO strain ectodomain expressed in Pichia pastoris
Keywords: واکسن مالاریا; Malaria vaccine; cGMP production; Preclinical product assessment;
Immunological responses to a 39.8 kDa Plasmodium vivax tryptophan-rich antigen (PvTRAg39.8) among humans
Keywords: واکسن مالاریا; Plasmodium vivax; Tryptophan-rich antigen; Humoral and cellular immune response; Malaria vaccine; Cytokines
A Phase 1 trial of PfCP2.9: An AMA1/MSP1 chimeric recombinant protein vaccine for Plasmodium falciparum malaria
Keywords: واکسن مالاریا; Malaria vaccine; Clinical trial; Malaria
Adjuvant formulations possess differing efficacy in the potentiation of antibody and cell mediated responses to a human malaria vaccine under selective immune genes knockout environment
Keywords: واکسن مالاریا; Adjuvant; Immunomodulators; Cytokines; Knockout mice; Malaria vaccine; Merozoite surface; Protein 1
Flow cytometric analysis on cross-reactivity of human-specific CD monoclonal antibodies with splenocytes of Aotus nancymaae, a non-human primate model for biomedical research
Keywords: واکسن مالاریا; Aotus nancymaae, A. nancymaae; CD, cluster of differentiation; mAb, monoclonal antibody; PBMC, peripheral blood mononuclear cellsMonoclonal antibody; Non-human primate; Cluster of differentiation; Malaria vaccine; Flow cytometry
Effect of the malaria vaccine Combination B on merozoite surface antigen 2 diversity
Keywords: واکسن مالاریا; Plasmodium falciparum; Malaria vaccine; Breakthrough infection; Merozoite surface protein 2; Genetic diversity; Phylogenetic analysis
Immunogenicity of a recombinant malaria vaccine based on receptor binding domain of Plasmodium falciparum EBA-175
Keywords: واکسن مالاریا; Malaria vaccine; Erythrocyte invasion; Erythrocyte binding proteins; EBA-175